Finance

Lists
002286:SHE
Baolingbao Biology Co Ltd
CN¥8.42
-1.06%
(-0.090) 1D
Oct 14, 3:05:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002286...
Open
CN¥8.48
High
CN¥8.99
Low
CN¥8.21
Mkt. cap
3.25B
Avg. vol.
20.82M
Volume
27.92M
Dividend
1.07%
Quarterly dividend
CN¥0.02
Ex-dividend date
Oct 14, 2026
P/E ratio
22.44
52-wk high
CN¥11.69
52-wk low
CN¥7.15
EPS
CN¥0.38
Shares outstanding
379.98M
No. of employees
2K
Open
CN¥8.48
High
CN¥8.99
Low
CN¥8.21
Mkt. cap
3.25B
Avg. vol.
20.82M
Volume
27.92M
Dividend
1.07%
Quarterly dividend
CN¥0.02
Ex-dividend date
Oct 14, 2026
P/E ratio
22.44
52-wk high
CN¥11.69
52-wk low
CN¥7.15
EPS
CN¥0.38
Shares outstanding
379.98M
No. of employees
2K
News stories
From web sources and news partners
About Baolingbao Biology Co Ltd
CEO-
Employees1.5K
FoundedOct 16, 1997
Headquarters-
SectorFood
Websiteblb-cn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
727.13M
624.66M
747.84M
748.27M
Cost of goods sold
627.63M
546.10M
632.24M
645.06M
Cost of revenue
627.63M
546.10M
632.24M
645.06M
Research and development expenses
3.86M
2.20M
9.02M
9.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.56M
52.87M
39.61M
51.62M
Operating expense
53.22M
58.63M
56.06M
66.59M
Total operating expenses
680.85M
604.73M
688.30M
711.64M
Operating income
46.28M
19.93M
59.55M
36.62M
Other non operating income
2.85M
-4.24M
-3.97M
4.02M
EBT including unusual items
50.55M
17.98M
64.65M
34.93M
EBT excluding unusual items
43.82M
16.05M
55.92M
32.82M
Income tax expense
9.22M
1.35M
10.52M
6.75M
Effective tax rate
18.24%
7.51%
16.27%
19.31%
Other operating expenses
4.59M
4.04M
4.91M
4.23M
Net income
41.33M
16.63M
54.13M
28.19M
Net profit margin
5.68%
2.66%
7.24%
3.77%
Earnings per share
-
-
-
-
Interest and investment income
890.75K
332.63K
101.64K
6.15M
Interest expense
-2.17M
-1.32M
-2.31M
-1.57M
Net interest expenses
-1.28M
-988.69K
-2.21M
4.58M
Depreciation and amortization charges
-
-
-
-
EBITDA
75.81M
49.52M
89.14M
67.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps